To what extent is alcohol consumption in social gatherings associated with observance of COVID-19 restrictions? A rapid reviewCOVID-19 제한 준수와 관련된 사교 모임에서의 알코올 소비는 어느 정도입니까? 신속한 검토Review Published on 2022-07-252022-09-11 Journal: Journal of Global Health [Category] MERS, meta-analysis, [키워드] 95% confidence interval Abstract alcohol alcohol consumption association CINAHL Compliance conducted confounding factor confounding factors connection coronavirus COVID-19 Cross-sectional studies cross-sectional study database direction eligible event Evidence for inclusion global health Guidance help hygiene Intervention Joanna Briggs Institute measure Methodological quality moderate NPI NPIs observance Odds ratio OVID physical distancing Policy produced ProQuest Public public health measure public health measures public spaces recall bia recall bias reduced reported required Research risk Safe selection bia Selection bias social interaction statistically significant Study design suggested systematic review title understanding WHO with COVID-19 [DOI] 10.7189/jogh.12.13001 PMC 바로가기 [Article Type] Review
COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patientsCOVID-19는 입원 환자의 심방세동 발병 위험을 높입니다Article Published on 2022-07-142022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 바이오마커, 치료기술, 치료법, [키워드] 95% CI Adequate Affect Analysis association Atrial fibrillation atrial flutter Cohort Comorbidities Comorbidity COVID-19 COVID-19 negative COVID-19 positive patient COVID-19 positive patients demographics demonstrated described detect disease electronic medical record electronic medical records eligible for inclusion hospital Hospitalized hospitalized patient hospitalized patients increase increase in increased risk Infection mass morbidity morbidity and mortality multivariable logistic regression myocardial involvement Patient patients patients with COVID-19 PCR test reduce Retrospective study risk risk factor SARS-CoV-2 screened Symptoms Treatment treatment regimen treatment regimens while [DOI] 10.1038/s41598-022-16113-6 PMC 바로가기 [Article Type] Article
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022이탈리아의 5-11세 아동에서 SARS-CoV-2 감염 및 중증 COVID-19에 대한 BNT162b2 백신의 효과: 2022년 1월-4월의 후향적 분석Article Published on 2022-07-092022-09-11 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Admission Analysis appear approval B.1.1.529 BNT162b2 children completion COVID-19 death deaths decrease defined diagnosed Diagnosis dose doses effective Effectiveness eligible epidemiological for inclusion hospitalisation hospitalisations individual Infection information intensive care units Italian Italy less material municipality National of BNT162b2 Older Omicron variant peaked Pfizer-BioNTech previous diagnosis public health residence retrospective Retrospective analysis SARS-COV-2 infection severe COVID-19 study period Surveillance the vaccine translation vaccinated against COVID-19 vaccination Vaccine were excluded [DOI] 10.1016/S0140-6736(22)01185-0 PMC 바로가기 [Article Type] Article
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort studyObservational Study Published on 2022-07-012022-10-05 Journal: The Lancet. Healthy longevity [Category] COVID19(2023년), SARS, 변종, 임상, 진단, [키워드] age antibody Antibody Response binding blood sample booster vaccination Care CD4 T-cell Cellular immune response cellular response Clinical outcome Comorbidity COVID-19 COVID-19 vaccination COVID-19 vaccine CXCL10 production Department EDTA eligible exclusion criteria Factors for inclusion frailty functional groups humoral IFN-γ IL-2 immune dysregulation immune protection immune response Impaired individual Infection IQR median median age neutralisation Observational cohort study Older participant Post-vaccine quantified response risk factor Sample SARS-CoV-2 SARS-COV-2 infection second vaccination SFU significantly staff stratified T-cell Response TNFα vaccination vaccine doses variant spike was reduced were assessed [DOI] 10.1016/S2666-7568(22)00118-0 PMC 바로가기 [Article Type] Observational Study
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study유럽에서 백신 접종 및 미접종 암 환자 사이에서 SARS-CoV-2 오미크론(B.1.1.529) 변종 발생 결과: 후향적, 다기관, OnCovid 등록 연구 결과Multicenter Study Published on 2022-07-012022-09-11 Journal: The Lancet. Oncology [Category] COVID19(2023년), SARS, 변종, [키워드] adjusted odds ratio age Alpha Analysis B.1.1.529 B.1.1.7 B.1.617.2 Belgium booster dose cancer treatment Comorbidities Complication country COVID-19 COVID-19 diagnosis COVID-19 mortality database database lock death diagnosed diagnosed with COVID-19 diagnosis of COVID-19 diagnosis of SARS-CoV-2 eligible Europe excluded Follow-up for inclusion France Germany haematological malignancy hospitalisation improvement Italy laboratory-confirmed less malignancy measure median age men morbidity morbidity and mortality multicentre Older omicron oncology outbreak outcome oxygen Oxygen therapy pandemic participant Patient Patients with cancer prevaccination Protective receipt recruited Registered registry Remission reported retrospective Retrospective analysis SARS-CoV-2 Sex Spain Stage Standard of care status supplemental oxygen Support susceptible systemic anti-cancer therapy the SARS-CoV-2 Therapies therapy treated Trust vaccination Vaccine-induced immunity variant variant of SARS-CoV-2 women [DOI] 10.1016/S1470-2045(22)00273-X PMC 바로가기 [Article Type] Multicenter Study
SARS-CoV-2 Incidence, signs and symptoms and main risk factors for COVID-19 infection in Health Care Workers: A hospital-wide survey in Salvador, BrazilArticle Published on 2022-07-012022-11-15 Journal: The Brazilian journal of infectious diseases : an [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome affected age Ageusia antibody association Brazil Characteristics conducted coronavirus country COVID-19 COVID-19 infection cross-sectional ELISA evaluated Factor for inclusion HCW HCWs Health care healthcare worker higher risk hospital identify IgG IgG and IgM incidence Infection information knowledge likelihood logistic regression model mitigate occupational occupational health participant positive positive IgG antibody positive RT-PCR proportion Questionnaires Ratio reported risk factor RT-PCR Saliva SARS-CoV-2 SARS-CoV-2 antibodies selected significantly higher Social inequalities Symptom Symptoms tested the disease Topic variable with COVID-19 women Workplace [DOI] 10.1016/j.bjid.2022.102387 PMC 바로가기
A rapid review of machine learning approaches for telemedicine in the scope of COVID-19Review article Published on 2022-07-012022-10-05 Journal: Artificial intelligence in medicine [Category] 바이오마커, 진단, 치료기술, [키워드] article articles Combination conducted contribute Coverage COVID-19 COVID-19 pandemic data extraction database Evidence exclusion for inclusion IMPROVE literature review machine learning machine learning approach mitigate outbreak pandemic Patient remote monitoring Spread subject survey Telemedicine the disease Transmission Virtual care virus widespread [DOI] 10.1016/j.artmed.2022.102312 [Article Type] Review article
Ivermectin for preventing and treating COVID-19COVID-19 예방 및 치료를 위한 이버멕틴Review Published on 2022-06-212022-09-11 Journal: The Cochrane database of systematic reviews [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Admission adverse event adverse events all-cause mortality antiparasitic Antiviral approach ARMS Asymptomatic certainty certainty of evidence citation classification Clinical improvement clinical trial Cochrane COVID-19 Study Register coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 symptoms COVID-19 treatment Data collection database death discharged disease disease severity double-blind duration of symptom early stage early stages Efficacy Efficacy and safety eligible Evidence excluded for inclusion GRADE hospital identify in vitro include increase index Infection infection with SARS-CoV-2 inhibit inhibitory effect initial symptom Inpatient Inpatients Intervention Invasive mechanical ventilation investigated Ivermectin life mean difference Mental Meta-analysis Mild Moderate COVID-19 moderate-to-severe COVID-19 molecular hypothesis Mortality no effect non-randomized ongoing trial ongoing trials Open-label outcome Outpatient outpatients participant Participants people with COVID-19 physical Placebo placebo-controlled Postexposure Prophylaxis Prevent Quality of life question Randomized controlled trial Randomized controlled trials RCT RCTs receiving reduce Registered Replication Reporting request Research resolved risk Risk of bias risk ratio RoB 2 SARS-CoV-2 SARS-COV-2 infection Science Citation Index searched Selection Serious Adverse Event Serious Adverse Events Seven severe acute respiratory syndrome Coronavirus Standard of care treat treated treating COVID-19 Treatment Trial trials viral clearance virus Web of Science WHO WHO guideline worsening [DOI] 10.1002/14651858.CD015017.pub3 PMC 바로가기 [Article Type] Review
Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study임상시험 레지스트리에 등록되고 인쇄전 서버 및 학술지에 게재된 무작위 임상 시험에서 COVID-19에 대한 치료 표준: 횡단면 연구Article Published on 2022-06-172022-09-11 Journal: BMC Medical Research Methodology [Category] COVID19(2023년), SARS, 임상, [키워드] administration analgesics Analysis Antibiotics antipyretics Antiviral bioRxiv Care clinical clinical trial clinical trials Combination component components conducted coronavirus Corticosteroid Corticosteroids COVID-19 cross-sectional cross-sectional study detrimental disease effective eligible for inclusion group Immunomodulatory agent Immunomodulatory agents Intervention investigator investigators MOST National original Original research oxygen pandemic randomized clinical trial Randomized controlled trial ranged RCT RCTs recruitment Registered reported SARS-CoV-2 shown SOC Standard Standard of care treated Treatment treatment for COVID-19 treatment intervention treatment interventions Trial trials unique Vitamin vitamins were used [DOI] 10.1186/s12874-022-01646-1 PMC 바로가기 [Article Type] Article
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus studyReview article Published on 2022-06-142022-10-05 Journal: The Lancet. Respiratory Medicine [Category] 임상, [키워드] acute infection clinical care Clinical practice cognitive condition conducted Consensus consequence country COVID COVID-19 DelPhi Final for inclusion Health individual International involved literature review mental health nervous system outcome outcomes participant physical Research Symptoms [DOI] 10.1016/S2213-2600(22)00169-2 [Article Type] Review article